ArticleCureus2022

An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination.

Tibor Bakacs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.